Peripheral Ulcerative Keratitis Secondary to Atypical Hemolytic Uremic Syndrome.
Journal
Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
pubmed:
4
4
2020
medline:
4
8
2021
entrez:
4
4
2020
Statut:
ppublish
Résumé
To report a case of peripheral ulcerative keratitis secondary to atypical hemolytic uremic syndrome. We report the case of a 76-year-old man who presented with bilateral aggressive peripheral ulcerative keratitis. Clinical examinations and investigations are reported from the patients' admission. The patient had an extended workup for autoimmune and infectious etiologies that all returned negative. The laboratory work in conjunction with renal biopsy and clinical symptoms were consistent with atypical hemolytic uremic syndrome. The patient was treated with systemic steroids for his peripheral ulcerative keratitis and underlying systemic disease. Corneal glueing and amniotic membrane grafting was also performed. To our knowledge, we report the first known case of peripheral ulcerative keratitis secondary to atypical hemolytic uremic syndrome. In cases where the standard workup is negative, this diagnosis should be considered because it can have significant systemic morbidity.
Identifiants
pubmed: 32243423
doi: 10.1097/ICO.0000000000002317
pii: 00003226-202011000-00016
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1431-1432Références
Srinivasan M, Zegans ME, Zelefsky JR, et al. Clinical characteristics of Mooren's ulcer in South India. Br J Ophthalmol. 2007;91:570–575.
Eiferman RA, Carothers DJ, Yankeelov JA Jr. Peripheral rheumatoid ulceration and evidence for conjunctival collagenase production. Am J Ophthalmol. 1979;87:703–709.
Raina R, Grewal MK, Radhakrishnan Y, et al. Optimal management of atypical hemolytic uremic disease: challenges and solutions. Int J Nephrol Renovasc Dis. 2019;12:183–204.
Formeck C, Swiatecka-Urban A. Extra-renal manifestations of atypical hemolytic uremic syndrome. Pediatr Nephrol. 2019;34:1337–1348.
Ramos de Carvalho JE, Schlingemann RO, Oranje M, et al. Reversal of threatening blindness after initiation of eculizumab in Purtscher-like retinopathy secondary to atypical hemolytic uremic syndrome. Int Ophthalmol. 2017;38:399–407.
Greenwood GT. Case report of atypical hemolytic uremic syndrome with retinal arterial and venous occlusion treated with eculizumab. Int Med Case Rep J. 2015;8:235–239.
Zheng X, Gorovoy IR, Mao J, et al. Recurrent ocular involvement in pediatric atypical hemolytic ure- mic syndrome. J Pediatr Ophthalmol Strabismus. 2014;51:e62–e65.